Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2010 2
2011 3
2012 3
2013 3
2015 2
2016 6
2017 3
2018 5
2019 1
2020 4
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Epidemic history of hepatitis C virus genotypes and subtypes in Portugal.
Palladino C, Ezeonwumelu IJ, Marcelino R, Briz V, Moranguinho I, Serejo F, Velosa JF, Marinho RT, Borrego P, Taveira N. Palladino C, et al. Among authors: borrego p. Sci Rep. 2018 Aug 16;8(1):12266. doi: 10.1038/s41598-018-30528-0. Sci Rep. 2018. PMID: 30116054 Free PMC article.
Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isolates Leads to Frequent Development of Broad and Elite Antibody Neutralization in HIV-1-Infected Individuals.
Martin F, Marcelino JM, Palladino C, Bártolo I, Tracana S, Moranguinho I, Gonçalves P, Mateus R, Calado R, Borrego P, Leitner T, Clemente S, Taveira N. Martin F, et al. Among authors: borrego p. Microbiol Spectr. 2022 Dec 21;10(6):e0163422. doi: 10.1128/spectrum.01634-22. Epub 2022 Nov 29. Microbiol Spectr. 2022. PMID: 36445130 Free PMC article.
High Instantaneous Inhibitory Potential of Bictegravir and the New Spiro-β-Lactam BSS-730A for HIV-2 Isolates from RAL-Naïve and RAL-Failing Patients.
Bártolo I, Moranguinho I, Gonçalves P, Diniz AR, Borrego P, Martin F, Figueiredo I, Gomes P, Gonçalves F, Alves AJS, Alves N, Caixas U, Pinto IV, Barahona I, Pinho E Melo TMVD, Taveira N. Bártolo I, et al. Among authors: borrego p. Int J Mol Sci. 2022 Nov 18;23(22):14300. doi: 10.3390/ijms232214300. Int J Mol Sci. 2022. PMID: 36430777 Free PMC article.
Development of synthetic light-chain antibodies as novel and potent HIV fusion inhibitors.
Cunha-Santos C, Figueira TN, Borrego P, Oliveira SS, Rocha C, Couto A, Cantante C, Santos-Costa Q, Azevedo-Pereira JM, Fontes CM, Taveira N, Aires-Da-Silva F, Castanho MA, Veiga AS, Goncalves J. Cunha-Santos C, et al. Among authors: borrego p. AIDS. 2016 Jul 17;30(11):1691-701. doi: 10.1097/QAD.0000000000001108. AIDS. 2016. PMID: 27058352
Origin and epidemiological history of HIV-1 CRF14_BG.
Bártolo I, Abecasis AB, Borrego P, Barroso H, McCutchan F, Gomes P, Camacho R, Taveira N. Bártolo I, et al. Among authors: borrego p. PLoS One. 2011;6(9):e24130. doi: 10.1371/journal.pone.0024130. Epub 2011 Sep 28. PLoS One. 2011. PMID: 21969855 Free PMC article.
34 results